Search - tctmd.com

Displaying 921 - 940 of 1039

Sort: Relevancy | Date

Presentation Fellows 2012

Clinical Application of Multimodality Imaging: Vulnerable Plaque

Presenter: Gregg Stone

April 20, 2012

News Daily News

TRIGGER-PCI Published: Halted Trial Questions Platelet Testing in Stable Patients

April 19, 2012

News Daily News

Se Publica el TRIGGER-PCI: La Interrupción del Ensayo Cuestiona la Prueba Plaquetaria en Pacientes Estables

April 19, 2012

Presentation

Post ACC 2012 Late Breaking Trial Review

Presenter: Gregg W. Stone

April 18, 2012

Presentation

Late Breaking Trial Review

Presenter: Gregg W. Stone

April 13, 2012

News Daily News

Residual Syntax Score Predicts Outcome After Incomplete Revascularization

L.A. McKeown

April 10, 2012

News Daily News

La Puntuación Residual Syntax Predice los Resultados Tras una Revascularización Incompleta

L.A. McKeown

April 10, 2012

Presentation ACC 2012

Two-Year Results of the PLATINUM Randomized Trial Comparing Platinum Chromium PROMUS Element and Cobalt Chromium PROMUS/XIENCE V Everolimus-Eluting Stents in De Novo Coronary Artery Lesions

Presenter: Gregg Stone

March 28, 2012

News Industry News

Boston Scientific Supports New Clinical Trial to Evaluate Platinum Chromium Coronary Stents in Treating Heart Attack Patients

March 26, 2012

News Daily News

Meta-Analysis: Cobalt-Chromium EES Cut Stent Thrombosis Compared with BMS, Other DES

Caitlin E. Cox

March 25, 2012

News Daily News

Meta-Analysis: Cobalt-Chromium EES Cut Stent Thrombosis Compared with BMS, Other DES

Caitlin E. Cox

March 25, 2012

News Conference News ACC 2012

INFUSE-AMI: Bolus Abciximab Works, Thrombus Aspiration Doesn’t for Large STEMI

Jason Kahn

March 25, 2012

Presentation

INFUSE-AMI

Presenter: Gregg Stone

March 25, 2012

Presentation PCI Outcomes 2012

Controversy 1: Current Drug-Eluting Stents Are Not Only More Effective But Are Safer Than Bare Metal Stents and Should Be Used in more than 90% of (Stented) Patients

Presenter: Gregg W. Stone

March 23, 2012

News Industry News

Boston Scientific Announces New Clinical Data to be Presented at ACC 2012 on the Market-Leading PROMUS Element™ Stent

March 20, 2012

News Daily News

Renowned Interventionalist Geoffrey O. Hartzler Dies at Age 65

March 15, 2012

News Daily News

El Renonbrado Intervencionista Geoffrey O. Hartzler Fallece a los 65 Años

March 15, 2012

News Daily News

Un Registro Confirma que en el ‘Mundo Real’ la Bivalirudina es Mejor contra el STEMI

March 07, 2012

News Daily News

Registry Confirms Bivalirudin Better for STEMI in ‘Real World’

March 07, 2012

News Daily News

HORIZONS-AMI: Radial Access PCI Reduces Bleeding, MACE in STEMI

March 07, 2012

Advertisement

Clinical Application of Multimodality Imaging: Vulnerable Plaque

TRIGGER-PCI Published: Halted Trial Questions Platelet Testing in Stable Patients

Se Publica el TRIGGER-PCI: La Interrupción del Ensayo Cuestiona la Prueba Plaquetaria en Pacientes Estables

Post ACC 2012 Late Breaking Trial Review

Late Breaking Trial Review

Residual Syntax Score Predicts Outcome After Incomplete Revascularization

La Puntuación Residual Syntax Predice los Resultados Tras una Revascularización Incompleta

Two-Year Results of the PLATINUM Randomized Trial Comparing Platinum Chromium PROMUS Element and Cobalt Chromium PROMUS/XIENCE V Everolimus-Eluting Stents in De Novo Coronary Artery Lesions

Boston Scientific Supports New Clinical Trial to Evaluate Platinum Chromium Coronary Stents in Treating Heart Attack Patients

Meta-Analysis: Cobalt-Chromium EES Cut Stent Thrombosis Compared with BMS, Other DES

Meta-Analysis: Cobalt-Chromium EES Cut Stent Thrombosis Compared with BMS, Other DES

INFUSE-AMI: Bolus Abciximab Works, Thrombus Aspiration Doesn’t for Large STEMI

INFUSE-AMI

Controversy 1: Current Drug-Eluting Stents Are Not Only More Effective But Are Safer Than Bare Metal Stents and Should Be Used in more than 90% of (Stented) Patients

Boston Scientific Announces New Clinical Data to be Presented at ACC 2012 on the Market-Leading PROMUS Element™ Stent

Renowned Interventionalist Geoffrey O. Hartzler Dies at Age 65

El Renonbrado Intervencionista Geoffrey O. Hartzler Fallece a los 65 Años

Un Registro Confirma que en el ‘Mundo Real’ la Bivalirudina es Mejor contra el STEMI

Registry Confirms Bivalirudin Better for STEMI in ‘Real World’

HORIZONS-AMI: Radial Access PCI Reduces Bleeding, MACE in STEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content